1
Oliver, A, Canton, R, Campo, P, et al. (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science
288, 1251–1254.
2
Davies, JC (2002)
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev
3, 128–134.
3
Cantin, A (1995) Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med
151, 939–941.
4
Lyczak, JB, Cannon, CL & Pier, GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev
15, 194–222.
5
Davis, PB, Drumm, M & Konstan, MW (1996) Cystic fibrosis. Am J Respir Crit Care Med
154, 1229–1256.
6
Miles, EA & Calder, PC (2012) Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr
107, Suppl. 2, S171–S184.
7
Pierre, M, Husson, MO, Le Berre, R, et al. (2007) Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol
292, L1422–L1431.
8
Tiesset, H, Pierre, M, Desseyn, JL, et al. (2009) Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr
139, 82–89.
9
Anderson, BM & Ma, DW (2009) Are all n-3 polyunsaturated fatty acids created equal?
Lipids Health Dis
8, 33.
10
Yamamoto, N, St Claire, DA Jr, Homma, S, et al. (1988) Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res
48, 6044–6049.
11
Homma, S, Millman, I & Yamamoto, N (1990) A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes. Immunol Cell Biol
68, 137–142.
12
Ngwenya, BZ, Fiavey, NP & Mogashoa, MM (1991) Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids. Proc Soc Exp Biol Med
197, 91–97.
13
Mitre, R, Etienne, M, Martinais, S, et al. (2005) Humoral defence improvement and haematopoiesis stimulation in sows and offspring by oral supply of shark-liver oil to mothers during gestation and lactation. Br J Nutr
94, 753–762.
14
Ved, HS, Gustow, E, Mahadevan, V, et al. (1984) Dodecylglycerol. A new type of antibacterial agent which stimulates autolysin activity in Streptococcus faecium ATCC 9790. J Biol Chem
259, 8115–8121.
15
Brissette, JL, Cabacungan, EA & Pieringer, RA (1986) Studies on the antibacterial activity of dodecylglycerol. Its limited metabolism and inhibition of glycerolipid and lipoteichoic acid biosynthesis in Streptococcus mutans BHT. J Biol Chem
261, 6338–6345.
16
Reeves, PG, Rossow, KL & Lindlauf, J (1993) Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr
123, 1923–1931.
17
Phillipson, M & Kubes, P (2011) The neutrophil in vascular inflammation. Nat Med
17, 1381–1390.
18
Krysko, O, Vandenabeele, P, Krysko, DV, et al. (2010) Impairment of phagocytosis of apoptotic cells and its role in chronic airway diseases. Apoptosis
15, 1137–1146.
19
Armstrong, L, Jordan, N & Millar, A (1996) Interleukin 10 (IL-10) regulation of tumour necrosis factor α (TNF-α) from human alveolar macrophages and peripheral blood monocytes. Thorax
51, 143–149.
20
Cox, G (1996) IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol
271, L566–L571.
21
Tiesset, H, Bernard, H, Bartke, N, et al. (2011) (n-3) Long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr
− / − mice. J Nutr
141, 1101–1107.
22
Lee, SE, Lim, JW, Kim, JM, et al. (2014) Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori-infected gastric epithelial cells. Mediators Inflamm
2014, 128919.
23
Naqvi, AZ, Hasturk, H, Mu, L, et al. (2014) Docosahexaenoic acid and periodontitis in adults: a randomized controlled trial. J Dent Res
93, 767–773.
24
Oh, DY, Walenta, E, Akiyama, TE, et al. (2014) A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med
20, 942–947.
25
Cleland, LG, Caughey, GE, James, MJ, et al. (2006) Reduction of cardiovascular risk factors with long-term fish oil treatment in early rheumatoid arthritis. J Rheumatol
33, 1973–1979.
26
Larque, E, Gil-Sanchez, A, Prieto-Sanchez, MT, et al. (2012) Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr
107, Suppl. 2, S77–S84.
27
Schwerbrock, NM, Karlsson, EA, Shi, Q, et al. (2009) Fish oil-fed mice have impaired resistance to influenza infection. J Nutr
139, 1588–1594.
28
Morita, M, Kuba, K, Ichikawa, A, et al. (2013) The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell
153, 112–125.
29
Hekmatdoost, A, Wu, X, Morampudi, V, et al. (2013) Dietary oils modify the host immune response and colonic tissue damage following Citrobacter rodentium infection in mice. Am J Physiol Gastrointest Liver Physiol
304, G917–G928.
30
Calder, PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Br J Clin Pharmacol
75, 645–662.
31
Lotz, S, Aga, E, Wilde, I, et al. (2004) Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol
75, 467–477.
32
Maschmeyer, G & Braveny, I (2000) Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis
19, 915–925.
33
Bonfield, TL, Konstan, MW & Berger, M (1999) Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol
104, 72–78.
34
Chmiel, JF & Davis, PB (2003) State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
Respir Res
4, 8.
35
Freedman, SD, Katz, MH, Parker, EM, et al. (1999) A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr
( − / − ) mice. Proc Natl Acad Sci U S A
96, 13995–14000.
36
Dang, PM, Elbim, C, Marie, JC, et al. (2006) Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J
20, 1504–1506.
37
Cassatella, MA, Meda, L, Bonora, S, et al. (1993) Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med
178, 2207–2211.
38
Chmiel, JF, Konstan, MW, Saadane, A, et al. (2002) Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med
165, 1176–1181.
39
Taggart, C, Coakley, RJ, Greally, P, et al. (2000) Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol
278, L33–L41.
40
Ghosh, S, DeCoffe, D, Brown, K, et al. (2013) Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLOS ONE
8, e55468.
41
Murray, J, Barbara, JA, Dunkley, SA, et al. (1997) Regulation of neutrophil apoptosis by tumor necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro
. Blood
90, 2772–2783.
42
Weber, N (1985) Metabolism of orally administered rac-1-O-[1′-14C]dodecylglycerol and nutritional effects of dietary rac-1-O-dodecylglycerol in mice. J Lipid Res
26, 1412–1420.
